To include your compound in the COVID-19 Resource Center, submit it here.
Lupin Ltd. (NSE:LUPIN; BSE:500257) said it acquired anti-infectives company Symbiomix Therapeutics LLC (Newark, N.J.). The
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury